Nuclear receptors and their selective pharmacologic modulators
about
Nuclear Receptor Regulation of Aquaporin-2 in the KidneySmall Heterodimer Partner and Innate Immune RegulationROR nuclear receptors: structures, related diseases, and drug discoverySelective glucocorticoid receptor-activating adjuvant therapy in cancer treatmentsMinireview: Familiar Faces in Unfamiliar Places: The Emerging Role of Nuclear Receptors in Lung CancerRepresenting sex in the brain, one module at a time.What have we learned about GPER function in physiology and disease from knockout mice?Muscle as a "mediator" of systemic metabolismSelective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensorsInternational Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic ModulatorsSelective targeting of PPARγ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency.High Affinity Heme Binding to a Heme Regulatory Motif on the Nuclear Receptor Rev-erbβ Leads to Its Degradation and Indirectly Regulates Its Interaction with Nuclear Receptor CorepressorEstrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation.Core Circadian Clock Genes Regulate Leukemia Stem Cells in AMLSelective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapiesPharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritisBlockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells.Disentangling biological signaling networks by dynamic coupling of signaling lipids to modifying enzymes.Regulation of voltage-gated sodium channel expression in cancer: hormones, growth factors and auto-regulation.Modulation of nuclear receptor function by cellular redox poise.Biosynthesis of milk fat, protein, and lactose: roles of transcriptional and posttranscriptional regulation.Identification of Bexarotene as a PPARγ Antagonist with HDX.Role of the Thyroid System in Myelination and Neural Connectivity.Novel glucocorticoid receptor agonists in the treatment of asthma.Ligand Dependent Switch from RXR Homo- to RXR-NURR1 Heterodimerization.Research Resources for Nuclear Receptor Signaling Pathways.TRIENNIAL LACTATION SYMPOSIUM: Nutrigenomics in dairy cows: Nutrients, transcription factors, and techniques.Nuclear phosphoinositide regulation of chromatin.Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target.Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome.Effect of N-arachidonoyl-l-serine on human cerebromicrovascular endothelium.The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitisDesigned Spiroketal Protein Modulation.HDX reveals the conformational dynamics of DNA sequence specific VDR co-activator interactions.The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression.Estrogen Receptors Modulation of Anxiety-Like Behavior.Allosteric pathways in nuclear receptors - Potential targets for drug design.Vitamin D receptor activation induces P-glycoprotein and increases brain efflux of quinidine: an intracerebral microdialysis study in conscious rats.Regulation of Oligodendrocyte Differentiation and Myelination by Nuclear Receptors: Role in Neurodegenerative Disorders.Understanding mitochondrial biogenesis through energy sensing pathways and its translation in cardio-metabolic health.
P2860
Q26740554-BE43302A-7407-4973-A067-08FD04ECB23FQ26769682-ED5F9E60-5AD2-4B03-ABFB-519044A1320AQ26861208-5576280D-1A44-49C2-AD86-B2E9522845D0Q28078896-CCA4568B-679B-4154-A7B5-8F667D0D3E03Q33631471-0AAA91B5-22B7-4470-BB36-C9C7E1358458Q34033384-0C8CFF31-6320-47FE-882C-60559547A49CQ34485765-E8AC5DF5-48E3-42DA-8472-398029EDB687Q35429223-795C3A02-9FF1-45A7-9A55-68D26660B90DQ35684546-633B30B8-4D69-420B-8B4F-8B171224E0EBQ35795751-C24F50F4-4F13-4100-A57E-50592A776066Q35860302-C9D6BD6C-6AC5-4317-8120-F2FB87A1CA3CQ36518284-B535A5A0-E455-4878-BDB2-C518C69DA159Q36632405-4B9388ED-1099-45FD-93D4-72A2888AF789Q36783304-A4CD976D-2DEC-4199-A3B4-2C2D576CF0F9Q37186618-7625E16E-7278-4432-8C01-2E3AF5BE4702Q37460263-14D54876-D001-4F2A-A854-A33341F9542DQ37687668-D93FB4FB-C9C2-4BE4-9884-2A576C251DB9Q38157461-83C7BA10-682A-4EB5-9884-B0C34E86E706Q38184989-A133B42E-6D3D-498D-890A-F61C9D34CC24Q38185184-6FD1AD41-9DA9-4E71-AAFD-A2A80807D44EQ38294157-7BF5B34F-5F54-4BEF-85C3-FEA8BF284FC7Q38441741-8CAEF616-14FE-45C0-9AF5-8FB59ED44A58Q38542460-15D5951F-B7F1-4FC0-904F-A5FB7A8BEEBFQ38570469-E772955D-98DD-4911-AB5C-FD7CCB86DD5AQ38686743-B1E90AA0-8953-4B16-AB2B-CEDEC4A065EAQ38842436-C1C065E9-AFEE-4809-98C6-5AC086655776Q38934814-DFD2C045-9075-4046-BEA6-EFC63BB2BEC8Q39159757-46644E48-D076-411A-8EB2-04BB2CB5B7D5Q39309007-B533559F-5971-4A04-83D4-45638E87DDC2Q39557699-157CC546-E36B-45DE-ACA3-4B261AADC1E9Q41682627-8F34CDEE-D675-43CC-ADDD-A537EE62F8A1Q42010216-1B5CB2EE-52BE-414F-9E0D-C7AACFC7AFD2Q42259127-70FD26CE-32BF-4446-814C-D717C1F6A3A4Q42377219-FAAEFD1A-9060-41FD-B502-990AE3E7E0C0Q42576338-C1557153-5DF9-49D1-BE87-19BB99E2F3F1Q47356219-6E3D77A2-775B-4BE5-8EEB-0D9A9FD273E4Q47591223-FAD73E96-5DB2-4F82-8A3B-50255EA3DE8EQ48484054-0C7791D4-06C9-482C-B7F0-C8102085D2BEQ48986828-ADD766C2-40AD-4188-A395-44404F9B0DBCQ50087935-2B983EF6-4683-4B60-83E3-AB33772DD472
P2860
Nuclear receptors and their selective pharmacologic modulators
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Nuclear receptors and their selective pharmacologic modulators
@ast
Nuclear receptors and their selective pharmacologic modulators
@en
Nuclear receptors and their selective pharmacologic modulators
@nl
type
label
Nuclear receptors and their selective pharmacologic modulators
@ast
Nuclear receptors and their selective pharmacologic modulators
@en
Nuclear receptors and their selective pharmacologic modulators
@nl
prefLabel
Nuclear receptors and their selective pharmacologic modulators
@ast
Nuclear receptors and their selective pharmacologic modulators
@en
Nuclear receptors and their selective pharmacologic modulators
@nl
P2093
P3181
P356
P1476
Nuclear receptors and their selective pharmacologic modulators
@en
P2093
Christine Crumbley
Douglas J Kojetin
Laura A Solt
Subhashis Banerjee
Thomas Lundasen
Travis Hughes
Yongjun Wang
P304
P3181
P356
10.1124/PR.112.006833
P407
P577
2013-03-01T00:00:00Z